Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease

British Journal of Surgery

Volumn 90, Issue 9, 2003, Pages 1137-1141

  Mohan, P ^a   Safi, K ^a   Little, D M ^a   Donohoe, J ^a   Conlon, P ^a   Walshe, J J ^a   O'Kelly, P ^a   Thompson, C J ^a   Hickey, D P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; STEROID; TACROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141852884     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4208     Document Type: Article

References (29)

1. Currie CJ, Krause D, Morgan CL, Gill L, Stott NC, Peters JR. NHS acute sector expenditure for diabetes; the present, future, and excess in-patient cost of care. Diabetes Med 1997; 14: 686-692.
2. Centers for Disease Control and Prevention. National Diabetic Fact Sheet. US Department of Health and Human Services: Washington, 1998.
3. Manske CL, Wang Y, Thomas W. Mortality of cadaveric kidney transplantation versus combined kidney-pancreas transplantation in diabetic patients. Lancet 1995; 346: 1658-1662.
4. International Pancreas Transplant Registry 2001; 13: 1 http://www.iptr.umn.edu [December 2001].
5. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Maurer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
6. Cheung ATW, Perez RV, Chen PCY. Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: a computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation 1999; 68: 927-932.
7. Gaber AO, el-Gebely S, Sugathan P, Elmer DS, Hathaway DK, McCully RB et al. Early improvement in cardiac function occurs in pancreas-kidney but not diabetic kidney-alone transplant recipients. Transplantation 1995; 59: 1105-1112.
8. Foger B, Konigsrainer A, Palos G, Brandstatter E, Ritsch A, Konig P et al. Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol. Transplantation 1994; 58: 899-904.
9. Nankivell BJ, al-Harbi IS, Morris J, Clouston PD, O'Connell PJ, Chapman JR et al. Recovery of diabetic neuropathy after pancreas transplantation. Transplant Proc 1997; 29: 658-659.
10. American Diabetes Association. Clinical Practice Recommendations 2000. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2000; 23(Suppl 1): S85.
11. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67: 645-648.
12. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82-90.
13. Smets YF, Westendorp RG, van der Pijl JW, Th de Charro FT, Ringers J, de Fijte JW et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915-1919.
14. Becker BN, Brazy PC, Becker YT, Odorico JS, Pintar TJ, Collins BH et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129-2135.
15. La Rocca E, Fiorina P, Astorri E, Rossetti C, Lucignani G, Fazio F et al. Patient survival and cardiovascular events after kidney pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplantation 2000; 9: 929-932.
16. Sollinger HW, Stratta RJ, Kalayoglu M, Pirsch JD, Belzer FO. Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression. Surgery 1987; 102: 674-679.
17. Mohan P, Murphy DM, Counihan A, Cunningham P, Hickey DP. The role of intraoperative heparin in cyclosporine treated cadaveric renal transplant recipients. J Urol 1999; 162: 682-684.
18. National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System: USRDS Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, 1999.
19. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313.
20. Aker S, Ivens K, Grabensee B, Heering P. Cardiovascular risk factors and diseases after renal transplantation. Int Urol Nephrol 1998; 30: 777-788.
21. Vesco L, Busson M, Bedrossian J, Bitker MO, Hiesse C, Lang P. Diabetes mellitus after renal transplantation; characteristics, outcome, and risk factors. Transplantation 1996; 61: 1475-1478.
22. Manske CL. Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S157-S171.
23. Raj DSC, Choudhury D, Welbourne TC, Levi M. Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 2000; 35: 365-380.
24. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S142-S156.
25. Morel P, Goetz FC, Moudry-Munns K, Freier E, Sutherland DER. Long-term glucose control in patients with pancreatic transplant. Ann Intern Med 1991; 115: 694-699.
26. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993; 77: 976-981.
27. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
28. Ido Y, Vindigni A, Chang K, Stratum L, Chance R, Heath WF et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997; 277: 563-566.
29. Paty BW, Lanz K, Kendall DM, Sutherland DER, Robertson RP. Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 2001; 72: 1103-1107.